Recruitment and activation of tumor‐specific immune t cells in situ: Functional studies using a sponge matrix model
- 14 February 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 43 (2) , 310-316
- https://doi.org/10.1002/ijc.2910430225
Abstract
The activation of tumor-specific precursor cytotoxic T lymphocytes (CTLP) into cytotoxic T cells (CTL) was demonstrated in situ using the well-defined, highly metastatic ESb tumor as murine model system. Ten days after optimal immunization of syngeneic mice with a sublethal dose of live ESb tumor cells in the pinna, tumor-sensitized non-cytotoxic CTLP were recovered from the spleen and lymph nodes. These cells mature into tumor-specific CTL upon restimulation in vitro. Using a confined sponge matrix compartment, in combination with a specific tumor vaccine (autologous inactivated tumor cells), we induced a CD8+ (Lyt 2+) T-cell-mediated, highly cytotoxic anti-tumor immune response in situ in immunized mice. It was not possible to activate a similar response directly in lymphoid organs such as the spleen. The cytotoxic CD8+ T cells, recovered by simple mechanical pressing of the sponge, were active against the specific tumor cells in a 51Cr-release assay in vitro and also in a Winn neutralization assay in vivo. CTL activity was increased and remained in the non-adherent fraction when the cell mixture, squeezed out of the sponges, was passed over nylon wool. In a cell recruitment assay, the delayed-type hypersensitivity (DTH) potential of the activated sponge-infiltrating T cells was demonstrated by their capacity to recruit circulating host lymphocytes to sites of tumor-cell location in situ.This publication has 26 references indexed in Scilit:
- Growth and metastasis of human tumors in nude mice following tumor-cell inoculation into a vascularized polyurethane sponge matrixInternational Journal of Cancer, 1988
- CD4+ helper T cells are required for resistance to a highly metastatic murine tumorEuropean Journal of Immunology, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytesCellular Immunology, 1986
- Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effectsInternational Journal of Cancer, 1986
- Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocaricinoma. i. characterization of anin situ lymphocyte suppressor population by surface markers and functional reactivityInternational Journal of Cancer, 1984
- RECRUITMENT OF UNSENSITIZED CIRCULATING LYMPHOCYTES TO SITES OF ALLOGENEIC CELLULAR INTERACTIONSTransplantation, 1982
- MIGRATION AND CELL RECRUITING ACTIVITY OF SPECIFICALLY SENSITIZED LYMPHOCYTES IN SPONGE MATRIX ALLOGRAFTSTransplantation, 1980
- Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Ia- and Ia+ helper T cells.The Journal of Experimental Medicine, 1978
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973